Irina is a member of the Practice Area Patents Technology and Life Sciences and the Life Science & Healthcare Industry Group. She advises national and international pharmaceutical and medical device companies on regulatory aspects and industry-specific agreements.

Show full CV Hide full CV

Latest news & insights

Life sciences & healthcare

R&D Collaborations | Coffee Break Life Sciences Start-ups #4

18 April 2024
In-depth analysis

by Dr. Stefanie Greifeneder and Irina Rebin

Click here to find out more
Life sciences & healthcare

Germany as a location for pharmaceutical businesses - quo vadis, 2024?

Strategy paper by the German Federal Government on improving the regulatory framework for the pharmaceutical industry in Germany

11 January 2024
In-depth analysis

by Dr. Manja Epping and Irina Rebin

Click here to find out more
Patents & innovation

JUVE Awards 2023: Taylor Wessing named "Law Firm of the Year for IP”

27 October 2023

by multiple authors

Click here to find out more
Commercial & consumer contracts

The Long and Winding Road: (Some) EU and FDA Issues to Consider with Clinical Trials and Clinical Trial Agreements

21 September 2023
In-depth analysis

by Dr. Manja Epping and Irina Rebin

Click here to find out more

Meet me at

20 November

10:00 - 10:30

Webinar

Regulatory peculiarities: AI used in medical devices, combination products and companion diagnostics | Coffee Break Life Sciences Start-ups #11

More